DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 146 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.99 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,227,000 | -62.8% | 209,686 | -31.2% | 1.07% | -57.0% |
| Q2 2021 | $11,371,000 | +46.6% | 304,686 | +0.5% | 2.49% | +38.1% |
| Q1 2021 | $7,755,000 | +6.2% | 303,268 | -8.5% | 1.80% | -3.8% |
| Q4 2020 | $7,303,000 | +24.6% | 331,513 | +1.7% | 1.87% | +20.6% |
| Q3 2020 | $5,862,000 | -23.3% | 325,863 | +8.3% | 1.55% | -27.9% |
| Q2 2020 | $7,640,000 | +38.3% | 300,805 | 0.0% | 2.15% | -16.0% |
| Q1 2020 | $5,526,000 | +4.5% | 300,805 | +25.3% | 2.56% | +67.8% |
| Q4 2019 | $5,287,000 | – | 240,000 | – | 1.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,705,392 | $43,607,000 | 7.88% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $78,762,000 | 4.46% |
| DAFNA Capital Management LLC | 587,756 | $15,029,000 | 3.57% |
| RTW INVESTMENTS, LP | 7,463,291 | $190,836,000 | 2.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $5,114,000 | 2.79% |
| Evolutionary Tree Capital Management, LLC | 122,473 | $3,132,000 | 1.85% |
| Parkman Healthcare Partners LLC | 303,268 | $7,755,000 | 1.80% |
| Eagle Health Investments LP | 161,125 | $4,120,000 | 1.62% |
| BRIDGER MANAGEMENT, LLC | 588,910 | $15,058,000 | 1.41% |
| Woodline Partners LP | 1,777,000 | $45,438,000 | 1.01% |